Radionetics Oncology

Focus: Radionetics Oncology is a radiopharmaceutical specialist focused on oncology and neurology therapeutics based in San Diego. The company operates in the niche but growing field of targeted radiopharmaceuticals for cancer treatment.

Oncology Neurology

Profile data last refreshed Yesterday · AI intelligence enriched 1w ago

Open Jobs

About Radionetics Oncology

AI assessmentNot Hiring

No open roles listed right now. Follow Radionetics Oncology to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

3 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

68Ga-R8760 injection at pre-defined dose levels

Adrenocortical Carcinoma

Phase 1

Clinical Trials (1)

NCT05999292Phase 1 Study of 68Ga-R8760

Phase 1

Help build intelligence for Radionetics Oncology

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Opportunity to build expertise in radiopharmaceuticals, an emerging and underserved modality with significant FDA momentum and commercial potential
Based in San Diego biotech hub with access to world-class research institutions and talent networks
Ground-floor opportunity at a focused, mission-driven oncology company in a high-growth therapeutic area

Watch Out For

No active job openings currently listed, suggesting limited near-term hiring momentum or possible development stage constraints
Limited publicly available data on funding, financials, pipeline, and trial activity raises questions about transparency and development progress
Early-stage company with no commercial revenue or approved products represents higher career risk than established players

Generated by Claude from Radionetics Oncology's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

68Ga-R10602 injection

Locoregionally Recurrent Hormone-receptor Positive Breast Cancer

Phase 1

Clinical Trials (1)

NCT06745804Study of 68Ga-R10602

Phase 1

68Ga-R11228

Locoregionally Recurrent Hormone-receptor Positive Breast Cancer

Phase 1

Clinical Trials (1)

NCT07121244A Phase 1 Study of 68Ga-R11228 and 177Lu-R11228 in Breast Cancer

Phase 1

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 3 clinical trials

Top TAs: Oncology

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Therapeutic Area Focus

Oncology

3 pipeline

Marketed

Pipeline